NAD+
Men's HealthMale-physiology practitioners evaluate NAD+ against the HPG axis, androgenic markers, and downstream effects on body composition, libido, and recovery. Coenzyme for over 500 enzymatic reactions including oxidative phosphorylation, glycolysis, fatty acid β-oxidation, and the citric acid cycle Critically, NAD+ is the substrate consumed by sirtuins (SIRT1-7) and PARPs — both depend on adequate NAD+ for their longevity- and DNA-repair-related functions. NAD+ levels decline approximately 50% from age 20 to 60.. For men running NAD+ alongside TRT, post-cycle restarts, or fertility-aware protocols, baseline labs (total/free testosterone, LH, FSH, estradiol, prolactin, SHBG) and a 6-8 week follow-up panel are the standard monitoring framework at the 100-1000 mg 1x weekly iv; daily subq at lower doses dose.
Key Takeaways
Male-physiology lens: NAD+ is evaluated against HPG-axis interaction, TRT compatibility, and prostate / cardiovascular considerations. Mechanism: Coenzyme for over 500 enzymatic reactions including oxidative phosphorylation, glycolysis, fatty acid β-oxidation, and the citric acid cycle. Male monitoring: baseline testosterone (total/free), LH, FSH, estradiol, prolactin, SHBG; 6-8 week follow-up panel. Male dose: 100-1000 mg 1x weekly iv; daily subq at lower doses via iv/subq/intranasal/oral precursors (nr/nmn); cycle 8-12 weeks. Male-physiology stack partners: Kisspeptin, Gonadorelin (GnRH), PT-141.
Male users' practical questions about NAD+ reduce to: hormonal coherence, TRT integration, and prostate / cardiovascular safety. Coenzyme for over 500 enzymatic reactions including oxidative phosphorylation, glycolysis, fatty acid β-oxidation, and the citric acid cycle. Critically, NAD+ is the substrate consumed by sirtuins (SIRT1-7) and PARPs — both depend on adequate NAD+ for their longevity- and DNA-repair-related functions. NAD+ levels decline approximately 50% from age 20 to 60. The mechanism shapes the answer to each. The subsections below work through HPG-axis impact and TRT compatibility before examining the body composition and male-physiology response.
Compatibility with TRT and post-cycle protocols
For men currently on TRT or planning a post-cycle restart, NAD+ is typically compatible because it does not directly engage the HPG axis. The dominant interaction to watch for is on the metabolic and recovery layers rather than the hormonal layer. Where the molecule's pharmacology overlaps with HCG, gonadorelin, or kisspeptin, dose layering is the standard approach.
Sexual function and prostate considerations
Where NAD+ alters circulating LH, testosterone, or local androgen signalling, prostate considerations become relevant for men over 40. Baseline PSA, periodic re-check, and avoidance of stacking that compounds androgenic load are all reasonable precautions. For molecules whose effects are predominantly outside the HPG axis, the prostate consideration is largely background.
Male body composition and performance response
Male users typically respond to NAD+ on the recovery, lean-mass, or visceral-fat dimension depending on the compound's primary pharmacology. Coenzyme for over 500 enzymatic reactions including oxidative phosphorylation, glycolysis, fatty acid β-oxidation, and the citric acid cycle. Critically, NAD+ is the substrate consumed by sirtuins (SIRT1-7) and PARPs — both depend on adequate NAD+ for their longevity- and DNA-repair-related functions. NAD+ levels decline approximately 50% from age 20 to 60. For men whose body composition goals are driven by training, the dose-timing relative to workouts and sleep is often the critical lever rather than the absolute dose itself.
Where male users target muscle mass, NAD+ is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.
Erectile Function in men responds to NAD+ with effect sizes that vary substantially by baseline status — men with documented suboptimal status respond more strongly than those at the upper end of normal. The protocol pattern in clinical use reflects this.
For fat loss (male) in male users, NAD+ is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.
Where male users target hair loss, NAD+ is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | IV | 100-1000 mg | 8–12 weeks on / 4 weeks off |
| Conservative starter | IV | 60-1000 mg | 4–6 weeks initial cycle |
| Men's Health focus | IV | 100-1000 mg | 1x weekly IV; daily SubQ at lower doses |
| Maintenance phase | IV | 70-1000 mg | Ongoing with periodic pauses |
Dose timing for NAD+ is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses.
NAD+ stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from men's-health clinicians.
- NAD+ + Kisspeptin: Activates the KISS1R (GPR54) on GnRH neurons in the hypothalamus, triggering GnRH release. Pairs naturally with NAD+'s mechanism in male physiology protocols.
- NAD+ + Gonadorelin (GnRH): Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. Pairs naturally with NAD+'s mechanism in male physiology protocols.
- NAD+ + PT-141: Activates MC4R in the hypothalamus and other CNS regions involved in sexual response. Pairs naturally with NAD+'s mechanism in male physiology protocols.
- NAD+ + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with NAD+'s mechanism in male physiology protocols.
Flushing common with IV (rate-dependent). Mild GI upset. Pretreatment with niacinamide can reduce flush.
Lens-specific safety considerations for male physiology use of NAD+: Flushing common with IV (rate-dependent). Mild GI upset. Pretreatment with niacinamide can reduce flush. Additional male physiology monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| NAD+ | Pyridine nucleotide cofactor | Hours; cellular pool dynamic | Men's Health |
| Kisspeptin | Hypothalamic upstream regulator of GnRH | ~28 min IV | The upstream master regulator of GnRH neurons — driving the entire HPG axis from above |
| Gonadorelin (GnRH) | Hypothalamic decapeptide | ~2-4 min | The natural decapeptide that drives pituitary release of LH and FSH — used clinically and increasingly as an HCG alternative during testosterone therapy |
| PT-141 | Melanocortin receptor agonist | ~2-3 hr | An MC3R/MC4R agonist derived from Melanotan II — FDA-approved as bremelanotide for HSDD in premenopausal women |
How does NAD+ affect the HPG axis?
Does NAD+ affect hair, prostate, or erythrocyte production?
Best time of day to dose for male users?
Is NAD+ compatible with TRT?
What is the standard dosing protocol for NAD+?
How does NAD+'s half-life affect dosing?
Start a NAD+ Protocol
Alukard provides physician-supervised men's health protocols with GMP-certified NAD+ and GMP-certified compounds with comprehensive hormone panels.
Get ProtocolQuick Facts
- Molecular weight
- 663 Da
- Half-life
- Hours; cellular pool dynamic
- WADA
- Not on prohibited list
- FDA
- Approved by various routes for various uses; mass-dose IV is off-label
All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for NAD+ unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Male Physiology Protocol for NAD+
Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.
HIPAA Compliant · GMP Certified · Physician Supervised